A8D Net Income From Continuing Ops from 2010 to 2026
| A8D Stock | 1.32 0.05 3.94% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -9 M | Current Value -9.5 M | Quarterly Volatility 8.1 M |
Check AB SCIENCE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AB SCIENCE's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 0.0 or Interest Expense of 2.7 M, as well as many indicators such as . A8D financial statements analysis is a perfect complement when working with AB SCIENCE Valuation or Volatility modules.
A8D | Net Income From Continuing Ops |
The evolution of Net Income From Continuing Ops for AB SCIENCE provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how AB SCIENCE compares to historical norms and industry peers.
Latest AB SCIENCE's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of AB SCIENCE over the last few years. It is AB SCIENCE's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AB SCIENCE's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
A8D Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (20,599,938) | |
| Coefficient Of Variation | (39.12) | |
| Mean Deviation | 7,387,720 | |
| Median | (26,061,000) | |
| Standard Deviation | 8,058,977 | |
| Sample Variance | 64.9T | |
| Range | 19.9M | |
| R-Value | 0.92 | |
| Mean Square Error | 10.2T | |
| R-Squared | 0.85 | |
| Slope | 1,473,376 | |
| Total Sum of Squares | 1039.2T |
A8D Net Income From Continuing Ops History
About AB SCIENCE Financial Statements
AB SCIENCE shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although AB SCIENCE investors may analyze each financial statement separately, they are all interrelated. The changes in AB SCIENCE's assets and liabilities, for example, are also reflected in the revenues and expenses on on AB SCIENCE's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -9 M | -9.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for A8D Stock Analysis
When running AB SCIENCE's price analysis, check to measure AB SCIENCE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB SCIENCE is operating at the current time. Most of AB SCIENCE's value examination focuses on studying past and present price action to predict the probability of AB SCIENCE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB SCIENCE's price. Additionally, you may evaluate how the addition of AB SCIENCE to your portfolios can decrease your overall portfolio volatility.